IL103106A - Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them - Google Patents

Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103106A
IL103106A IL103106A IL10310692A IL103106A IL 103106 A IL103106 A IL 103106A IL 103106 A IL103106 A IL 103106A IL 10310692 A IL10310692 A IL 10310692A IL 103106 A IL103106 A IL 103106A
Authority
IL
Israel
Prior art keywords
formula
alkyl
acid
represent
compounds
Prior art date
Application number
IL103106A
Other languages
English (en)
Other versions
IL103106A0 (en
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of IL103106A0 publication Critical patent/IL103106A0/xx
Publication of IL103106A publication Critical patent/IL103106A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C07D333/10—Thiophene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL103106A 1991-09-25 1992-09-08 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them IL103106A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9111822 1991-09-25

Publications (2)

Publication Number Publication Date
IL103106A0 IL103106A0 (en) 1993-02-21
IL103106A true IL103106A (en) 1998-06-15

Family

ID=9417295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103106A IL103106A (en) 1991-09-25 1992-09-08 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US5252749A (de)
EP (1) EP0534856B1 (de)
JP (1) JP3162822B2 (de)
KR (1) KR100199848B1 (de)
AR (1) AR248275A1 (de)
AT (1) ATE157360T1 (de)
AU (1) AU652072B2 (de)
BR (1) BR9203744A (de)
CA (1) CA2079016A1 (de)
CZ (1) CZ281936B6 (de)
DE (1) DE69221802T2 (de)
DK (1) DK0534856T3 (de)
ES (1) ES2108098T3 (de)
FI (1) FI106458B (de)
GR (1) GR3025335T3 (de)
HU (1) HU218204B (de)
IL (1) IL103106A (de)
MX (1) MX9205390A (de)
NO (1) NO301327B1 (de)
NZ (1) NZ244452A (de)
PH (1) PH30225A (de)
RU (1) RU2060253C1 (de)
ZA (1) ZA927318B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
FR2765107B1 (fr) * 1997-06-26 2000-03-24 Sanofi Sa Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
ATE315559T1 (de) * 2001-08-01 2006-02-15 Basell Polyolefine Gmbh Verfahren zur herstellung von heterocyclischen pentalen derivaten
US7432328B2 (en) * 2005-06-14 2008-10-07 Univation Technologies, Llc Enhanced ESCR bimodal HDPE for blow molding applications

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371190B (de) * 1972-03-24 1974-11-11 Kabi Ab
US3301874A (en) * 1963-12-26 1967-01-31 Sam Joseph Thienocyclopentanone antibacterial agents
SE371193B (de) * 1972-03-24 1974-11-11 Kabi Ab
US4156670A (en) * 1976-03-23 1979-05-29 American Cyanamid Company Substituted tetrahydrobenzothiophenes and method of preparation thereof
FR2471980A1 (fr) * 1979-12-21 1981-06-26 Sanofi Sa Nouveaux derives de l'amino-1 propanol-2, leur procede de preparation et leur application therapeutique
FR2567125B1 (fr) * 1984-07-09 1986-12-05 Lipha Acides dihydro-5,6-4h-cyclopenta (b) thiophenecarboxylique-6, procedes de preparation et medicaments les contenant
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CZ291892A3 (en) 1993-04-14
GR3025335T3 (en) 1998-02-27
PH30225A (en) 1997-02-05
MX9205390A (es) 1993-05-01
CZ281936B6 (cs) 1997-04-16
ES2108098T3 (es) 1997-12-16
JPH05213932A (ja) 1993-08-24
AU652072B2 (en) 1994-08-11
FI924281A0 (fi) 1992-09-24
IL103106A0 (en) 1993-02-21
US5252749A (en) 1993-10-12
DE69221802D1 (de) 1997-10-02
NO301327B1 (no) 1997-10-13
CA2079016A1 (en) 1993-03-26
FI924281L (fi) 1993-03-26
FI106458B (fi) 2001-02-15
NO923720D0 (no) 1992-09-24
AU2454892A (en) 1993-04-01
HU218204B (hu) 2000-06-28
RU2060253C1 (ru) 1996-05-20
JP3162822B2 (ja) 2001-05-08
EP0534856A1 (de) 1993-03-31
NZ244452A (en) 1994-08-26
NO923720L (no) 1993-03-26
ZA927318B (en) 1994-03-24
ATE157360T1 (de) 1997-09-15
DE69221802T2 (de) 1998-04-02
DK0534856T3 (da) 1998-04-20
BR9203744A (pt) 1994-03-29
KR100199848B1 (ko) 1999-06-15
HU9203050D0 (en) 1992-12-28
EP0534856B1 (de) 1997-08-27
HUT62876A (en) 1993-06-28
AR248275A1 (es) 1995-07-12
KR930006001A (ko) 1993-04-20

Similar Documents

Publication Publication Date Title
PL181165B1 (pl) Pochodne podstawionego chromanu, sposób ich wytwarzania oraz preparat farmaceutyczny
JPH04506222A (ja) N−置換複素環誘導体およびその製法
JPH02503317A (ja) 化合物
PT92446B (pt) Processo para a preparacao de eteres de oxima de propenona
JPH09505030A (ja) ヒドロイソキノリン誘導体
US20040077529A1 (en) Urotensin II receptor agents
CZ657890A3 (cs) Chromanový derivát, způsob jeho výroby a farmaceutický prostředek s jeho obsahem
HRP20020743A2 (en) Method for the preparation of citalopram
JP4740116B2 (ja) 精神疾患および神経障害の処置のための5−ht受容体アンタゴニスト
RU95122587A (ru) 1-фенилалканоны новые лиганды рецепторов 5-ht*004
JP2001512727A (ja) 5ht−1受容体のリガンドとしてのニ環式化合物
JP2001508420A (ja) ヘテロアリールスルホンアミド誘導体及びこれを含有する製薬学的組成物
TW200524864A (en) Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
AU652072B2 (en) Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them
GB2120662A (en) New azepinoindoles, their production and pharmaceutical compositions containing them
IE880970L (en) Benzofuran derivatives
JP2003505457A (ja) インドール誘導体
EP0233413A2 (de) 3-(2-Aminoethyl)indol und -indolinderivate, Verfahren zu ihrer Herstellung und diese Derivate enthaltende pharmazeutische Zusammensetzungen
JPH04234346A (ja) カルモデュリン阻害剤特性を有するベンズヒドリル誘導体
JPH0337549B2 (de)
US3503990A (en) 6-aryl-4,5,6,7-tetrahydro-4-oxoindole derivatives
JP3034556B2 (ja) 医薬用化合物類
HU176486B (en) Process for producing new 4-phenyl-thieno-square bracket-2,3-c-square bnacket closed -piperidine derivatives
JP2002541234A (ja) セロトニン再取り込みインヒビターとしての3−ビシクロアリール−2−アミノメチルビシクロアルカン
JP2002533447A (ja) 神経疾患の治療に有用な1,4−ジアザシクロヘプタン誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
RH1 Patent not in force